~~<i id='167E204E94'><strike id='167E204E94'><tt id='167E204E94'><pre id='167E204E94'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

author：entertainment 2025-10-01 06:01:45 - browse：33447

An advisory panel to the Food and Drug Administration delivered a split decision on a surgical system used in a controversial blood pressure treatment called renal denervation.

The panel, whose advice the FDA typically follows, voted that the system developed by ReCor Medical was safe and effective. It voted that the benefits of a system developed by Medtronic, however, did not outweigh the risks.

“While this is a very safe procedure, the efficacy was mild at best,” Keith Allen, director of surgical research at St. Luke’s Hospital of Kansas City, said regarding Medtronic’s device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Dewpoint Therapeutics lays off staff after losing partnerships

Wikipedia

hotspot

Wikipedia

focus

knowledge

DeepMindGoogleonWednesdayunveiledanartificialintelligencetoolcapableofpredictingthestructureandinter

WSS

Brain worms: The science behind RFK Jr.'s parasitic infection

What nurses really want: sufficient staffing for patient care

First recipient of genetically engineered pig kidney has died

Humana cuts profit projections as Medicare Advantage costs soar

Independent physicians launch a new lobbying group

Readout Newsletter: Merck, J&J, and long Covid

leisure time

leisure time

Wikipedia

Cancer drug shortages should be causing more outrage

Medicare says breakthrough device reimbursement rule to come by summer

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

How to improve immunocompromised access to mAb treatments

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout LOUD podcast: What to know about H5N1 bird flu

Affirmative action in medical school literally saved lives

Brain worms: The science behind RFK Jr.'s parasitic infection

Trump demands the U.S. pay no more for drugs than other countries … again

H5N1 bird flu: what we're starting to learn about infection in cows

hotspot

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Study: People of West African ancestry at greater risk of cardiac amyloidosis

My yearlong odyssey to get my son’s ADHD medication covered

How to improve immunocompromised access to mAb treatments

Medicare Advantage today, explained in one chart

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Wikipedia

focus

focus

knowledge